CYHNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
COMMUNITY HEALTH SYSTEMS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 23, 2026
$2.76−0.12 (-4.17%)
Close on Oct 19, 2026
- Market cap
- $376.75M
- P/E (TTM)
- 1.5
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
82.7%
117M of 141M shares
Institutional holders
181
30 new, 24 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
0 buys · 1 sales
Net sold $118.40K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 9,750,502 | 7.10% | 13G (passive) amendment | Dec 31, 2023 |
| CastleKnight Management LP | 9,748,536 | 7.00% | 13G (passive) amendment | Dec 31, 2025 |
| CastleKnight Management GP LLC | 9,401,740 | 6.80% | 13G (passive) amendment | Dec 31, 2024 |
| Kamran Moghtaderi | 8,458,020 | 6.10% | 13G (passive) amendment | Mar 31, 2025 |
| Eversept Partners, L.P. | 7,943,802 | 5.73% | 13G (passive) amendment | Dec 31, 2025 |
| Wayne T. Smith | 7,837,614 | 5.70% | 13G (passive) amendment | Dec 31, 2023 |
| He Zhengxu | 7,410,784 | 5.30% | 13G (passive) | May 14, 2026 |
| Nomura Global Financial Products Inc | 7,271,079 | 5.20% | 13G (passive) | Jun 30, 2025 |
| Weitman Capital LLC | 12,667,586 | 9.00% | 13G (passive) amendment | Mar 31, 2026 |
| Castleknight Master Fund LP | 12,262,508 | 8.80% | 13G (passive) amendment | Sep 30, 2025 |
| Apollo Management Holdings, L.P. | 11,859,526 | 8.40% | 13G (passive) amendment | Jun 30, 2026 |
| Apollo Capital Management GP, LLC | 11,489,316 | 8.20% | 13G (passive) amendment | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CYH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| CastleKnight Management LP | 13,384,586 | 9.49% | $44.70M | +717,000 | 0.61% |
| Apollo Management Holdings, L.P. | 11,859,526 | 8.41% | $39.61M | +370,210 | 0.44% |
| BlackRock, Inc. | 10,930,538 | 7.75% | $36.51M | +1,127,681 | 0.00% |
| Eversept Partners, LP | 7,864,575 | 5.58% | $26.27M | −812,706 | 1.36% |
| Nomura Holdings Inc | 6,703,109 | 4.75% | $22.39M | −181,900 | 0.03% |
| Vanguard Capital Management LLC | 5,289,931 | 3.75% | $17.67M | −85,572 | 0.00% |
| Whitebox Advisors LLC | 3,732,743 | 2.65% | $12.47M | +604,859 | 0.16% |
| Geode Capital Management, LLC | 3,167,702 | 2.25% | $10.58M | +260,097 | 0.00% |
| State Street Corp | 3,061,863 | 2.17% | $10.23M | +139,953 | 0.00% |
| Vanguard Portfolio Management LLC | 3,018,598 | 2.14% | $10.08M | +25,102 | 0.00% |
| Saba Capital Management, L.P. | 2,882,169 | 2.04% | $9.63M | +1,600,330 | 0.25% |
| SG Americas Securities, LLC | 2,722,023 | 1.93% | $9.09K | +2,689,066 | 0.01% |
| Owl Creek Asset Management, L.P. | 2,530,622 | 1.79% | $8.45M | – | 0.70% |
| Charles Schwab Investment Management Inc | 2,448,018 | 1.74% | $8.18M | −311,186 | 0.00% |
| Dimensional Fund Advisors LP | 2,351,460 | 1.67% | $7.85M | −92,158 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,344,128 | 1.66% | $7.83M | −24,388 | 0.00% |
| Aqr Capital Management LLC | 2,290,827 | 1.62% | $7.65M | +980,081 | 0.00% |
| Two Sigma Investments, LP | 2,205,336 | 1.56% | $7.37M | −795,070 | 0.01% |
| Diameter Capital Partners LP | 1,837,962 | 1.30% | $6.14M | New | 0.49% |
| Bank Of America Corp /De/ | 1,767,619 | 1.25% | $5.90M | +1,173,504 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 181 | 117M | 82.7% | 30 / 67 | 52 / 24 | 17M | 9M |
| Q1 2026 | 176 | 109M | 77.1% | 18 / 62 | 60 / 23 | 22M | 11M |
| Q4 2025 | 183 | 107M | 75.7% | 37 / 55 | 57 / 25 | 12M | 16M |
| Q3 2025 | 173 | 112M | 79.1% | 27 / 55 | 58 / 28 | 17M | 21M |
| Q2 2025 | 175 | 115M | 81.9% | 28 / 65 | 47 / 22 | 16M | 16M |
| Q1 2025 | 170 | 115M | 81.8% | 22 / 53 | 59 / 35 | 20M | 20M |
| Q4 2024 | 187 | 116M | 82.2% | 28 / 61 | 58 / 31 | 29M | 20M |
| Q3 2024 | 191 | 107M | 76.1% | 28 / 59 | 63 / 24 | 26M | 15M |
| Q2 2024 | 190 | 106M | 75.5% | 35 / 62 | 45 / 30 | 17M | 19M |
| Q1 2024 | 187 | 108M | 76.8% | 25 / 60 | 58 / 31 | 20M | 14M |
| Q4 2023 | 193 | 102M | 72.6% | 49 / 61 | 53 / 39 | 26M | 29M |
| Q3 2023 | 186 | 105M | 74.6% | 23 / 49 | 75 / 33 | 10M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of CYH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,813,888 | 2.70% | $12.74M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,488,937 | 2.47% | $11.65M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,417,416 | 1.01% | $3.95M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,347,631 | 0.96% | $4.50M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 1,230,623 | 0.87% | $4.11M | 0.03% | Jun 30, 2026 |
| Schwab Fundamental U.S. Large Company ETF | 1,126,552 | 0.80% | $3.06M | 0.01% | May 31, 2026 |
| PIMCO RAE US Small Fund | 994,208 | 0.71% | $3.32M | 0.09% | Jun 30, 2026 |
| Vanguard Explorer Fund | 768,760 | 0.55% | $2.14M | 0.01% | Jul 31, 2026 |
| Vanguard Strategic Equity Fund | 737,087 | 0.52% | $2.46M | 0.02% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 657,416 | 0.47% | $1.79M | 0.01% | May 31, 2026 |
| U.S. Small Cap Portfolio | 609,167 | 0.43% | $1.70M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 575,466 | 0.41% | $1.57M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 546,576 | 0.39% | $1.49M | 0.01% | May 31, 2026 |
| U.S. Micro Cap Portfolio | 473,828 | 0.34% | $1.32M | 0.02% | Jul 31, 2026 |
| Schwab Fundamental U.S. Large Company Index Fund | 459,234 | 0.33% | $1.28M | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Tim Hingtgen | CEO, Director | 1,267,588 | 0.90% | Mar 3, 2025 |
| David V. Rice | EVP-Clinical Operations & CMO | 30,000 | 0.02% | Jun 1, 2026 |
| Jason K. Johnson | EVP & CFO | 202,049 | 0.14% | Mar 3, 2026 |
| Kevin J. Hammons | CEO | 992,441 | 0.70% | Mar 3, 2026 |
| Kevin A. Stockton | EVP, Operations & Development | 213,863 | 0.15% | Mar 3, 2026 |
| Justin D. Pitt | Pres,Chief Legal&Admin Officer | 300,334 | 0.21% | Mar 3, 2026 |
| Phillip A. Posey | SVP & CAO | 52,924 | 0.04% | Mar 3, 2026 |
| Miguel S. Benet | President and CMO | 47,635 | 0.03% | Mar 3, 2025 |
| Austen D. Mason | Regional President | 142,500 | 0.10% | Mar 3, 2025 |
| Mark B. Medley | Regional President | 128,637 | 0.09% | Mar 3, 2025 |
| Chad A. Campbell | Regional President | 150,787 | 0.11% | Mar 3, 2025 |
| William Norris Jennings | Director | 38,468 | 0.03% | Aug 25, 2026 |
| K. Ranga Krishnan | Director | 170,023 | 0.12% | Jun 30, 2026 |
| Ronald L. Burgess Jr | Director | 0 | – | Mar 3, 2026 |
| John A. Clerico | Director | 368,763 | 0.26% | Mar 3, 2026 |
| John A. Fry | Director | 268,966 | 0.19% | Mar 3, 2026 |
| Michael Dinkins | Director | 204,976 | 0.15% | Mar 3, 2026 |
| Fawn D. Lopez | Director | 0 | – | Mar 3, 2026 |
| James S. Ely III | Director | 377,027 | 0.27% | Mar 3, 2026 |
| Wayne T. Smith | Director | 7,306,142 | 5.18% | Mar 3, 2026 |
| Hubert James Williams | Director | 171,024 | 0.12% | Mar 3, 2026 |
| Elizabeth T. Hirsch | Director | 142,126 | 0.10% | Mar 3, 2026 |
| Joseph Arthur Hastings | Director | 17,130 | 0.01% | Mar 3, 2026 |
| Susan W. Brooks | Director | 67,856 | 0.05% | Mar 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William Norris Jennings Director | Aug 25, 2026 | Sale | −40,000 | $2.96 | $118.40K | 38,468 |
| K. Ranga Krishnan Director | Jun 30, 2026 | Option exercise | +13,930 | – | – | 170,023 |
| David V. Rice EVP-Clinical Operations & CMO | Jun 1, 2026 | Award | +30,000 | – | – | 30,000 |
| K. Ranga Krishnan Director | Apr 22, 2026 | Option exercise | +46,950 | – | – | 156,093 |
| Wayne T. Smith Director | Mar 2, 2026 | Gift | −19,400 | – | – | 5,217,579 |
| Michael Dinkins Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 204,976 |
| Michael Dinkins Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 225,882 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Tax withholding | −24,922 | $3.46 | $86.23K | 287,750 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Award | +40,000 | – | – | 312,672 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Option exercise | +30,000 | – | – | 272,672 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 268,966 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 249,033 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 228,127 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 368,763 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 348,830 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 327,924 |
| Phillip A. Posey SVP & CAO | Mar 1, 2026 | Award | +25,000 | – | – | 52,924 |
| Phillip A. Posey SVP & CAO | Mar 1, 2026 | Tax withholding | −1,188 | $3.46 | $4.11K | 51,736 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 142,126 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 121,220 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 162,059 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 67,856 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 88,762 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 108,695 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 372,037 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 392,943 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 412,876 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Option exercise | +30,000 | – | – | 202,049 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Tax withholding | −23,610 | $3.46 | $81.69K | 268,439 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Award | +90,000 | – | – | 292,049 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Award | +200,000 | – | – | 992,441 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Tax withholding | −96,896 | $3.46 | $335.26K | 895,545 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Option exercise | +156,240 | – | – | 792,441 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 171,024 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 211,863 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 191,930 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Option exercise | +50,000 | – | – | 213,863 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Award | +30,000 | – | – | 243,863 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Tax withholding | −35,573 | $3.46 | $123.08K | 208,290 |
| James S. Ely III Director | Dec 31, 2025 | Option exercise | +2,882 | – | – | 362,281 |
| Susan W. Brooks Director | Jun 1, 2025 | Option exercise | +5,894 | – | – | 58,100 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 359,399 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 338,493 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 328,737 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 130,606 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 161,268 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 140,362 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 164,558 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 195,220 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 174,314 |
| Austen D. Mason Regional President | Mar 1, 2025 | Award | +25,000 | – | – | 142,500 |
| Austen D. Mason Regional President | Mar 1, 2025 | Option exercise | +10,500 | – | – | 117,500 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 80,802 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 111,464 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 90,558 |
| Mark B. Medley Regional President | Mar 1, 2025 | Tax withholding | −15,682 | $3.01 | $47.20K | 128,637 |
| Mark B. Medley Regional President | Mar 1, 2025 | Award | +25,000 | – | – | 144,319 |
| Mark B. Medley Regional President | Mar 1, 2025 | Option exercise | +10,500 | – | – | 119,319 |
| Susan W. Brooks Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 31,300 |
| Susan W. Brooks Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 52,206 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Norris Jennings William Director | Aug 25, 2026 | 40,000 | $120.00K | Aug 25, 2026 | RSU Vest |
| Hingtgen Tim former CEO | Dec 9, 2025 | 66,666 | $225.66K | Dec 9, 2025 | stock option |
| Hingtgen Tim former CEO | Oct 28, 2025 | 532,813 | $2.23M | Oct 28, 2025 | RSU |
| S. Benet Miguel Officer | Feb 25, 2025 | 23,875 | $84.04K | Feb 21, 2025 | RSA Vest |
| Pitt Rebecca Officer, spouse is officer | Aug 7, 2023 | 9,068 | $54.40K | Aug 7, 2023 | RSU vest |